Kazi Asraf Ali

Dr. Kazi Asraf Ali

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2022 in Encyclopedia
Verified
Journal Article
Open access
PDF file
CHChowdhury Mobaswar Hossain
Chowdhury Mobaswar Hossain
Lisa Kathleen RyanLisa Kathleen Ryan
Lisa Kathleen Ryan
GMGera Meeta
Gera Meeta
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
NLNazmun Lyle
Nazmun Lyle
Gill DiamondGill Diamond
Gill Diamond
Antifungal drugs prevent topical or invasive fungal infections (mycoses) either by stopping growth of fungi (termed fungistatic) or by killing the fungal cells (termed fungicidal). Antibiotics also prevent bacterial infections through either bacteriostatic or bactericidal mechanisms. These microorganisms successfully develop resistance against conventional drugs that are designed to kill or stop them from multiplying. When a fungus no longer responds to antifungal drug treatments and continues to grow, this is known as antifungal drug resistance. Bacteria have an amazing capacity to become resistant to antibiotic action as well, and the effectiveness of the scarce antifungal arsenal is jeopardised by this antibiotic resistance, which poses a severe threat to public health.

29 March 2024 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
KAKazi Asraf Ali
Kazi Asraf Ali
SMSk Mohin
Sk Mohin
PMPuja Mondal
Puja Mondal
SGSusmita Goswami
Susmita Goswami
SGSoumya Ghosh
Soumya Ghosh
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
Background: Artificial intelligence (AI) revolutionized the formulation and development of modern pharmaceuticals. With the help of AI, researchers can now optimize drug design, develop formulations, and streamline clinical trials in a much accurate and efficient way. Drug development might be greatly expedited and time-consuming procedure; however, with the help of AI this are significantly reduced. Main body of The main advantages of AI in pharmaceutical formulation are its capacity to analyse vast amounts of data and spot patterns and connections that human researchers would miss. Various tools and technologies, such as ANN, fuzzy logic, neuro-fuzzy logic, and genetic algorithm are used for analysing the date, of which ANN is popular and mostly used. AI enables the discovery of novel pharmacological targets and the creation of more potent medications. AI may also be used to improve medication formulations by forecasting the solubility, stability, and bioavailability of drug candidates, increasing the likelihood that clinical trials will be successful. AI is also applied in designing clinical trials, reducing the time and cost of the process by identifying patient populations that are most likely to benefit from the treatment. Additionally, AI can monitor patients during clinical trials, detecting real-time adverse effects and adjusting dosages to improve patient outcomes. Conclusion: AI is a potent pharmaceutical formulation and development tool, allowing researchers to analyse vast amounts of data, optimize drug formulations, and streamline clinical trials. As technology develops, experts anticipate that AI will increasingly show a crucial part in drug development, enabling faster, more efficient, and more effective treatments for various diseases.

7 December 2022 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
CHChowdhury Mobaswar Hossain
Chowdhury Mobaswar Hossain
MGMeeta Gera
Meeta Gera
KAKazi Asraf Ali
Kazi Asraf Ali
Conventional herbal medication has picked up a gigantic sum of intrigue around the world due to its viability in the treatment of extreme illnesses from the period of antiquated civilizations. Phytomedicines are considered a major health-care supplier around the globe, especially in rustic and farther ranges. A huge segment of individuals depends on or accept home-grown drugs as an essential cure for different afflictions rather than manufactured drugs. Researchers are paying much attention to herbal medicine as compared to synthetic drugs due to their severe side effects, and toxicity with less efficacy and specificity. Despite the significant increase in global interest in the investigation and development of new botanical products, only a few have been approved till now. Natural product medication development has significant technical and monetary hurdles, including a time-consuming formulation process, quality assurance, safety, therapeutic efficacy, promotion, and administrative issues. To meet these challenges, the regulatory agencies EMEA, ICH, AYUSH, DCGI, WHO, and U.S. FDA trying to bring these herbal drugs under the regulatory pipeline under the NDA approval process. Moreover, the process of drug discovery has also been revolutionized with the new advent of technologies such as the successful drug development of a novel therapeutic agent is critically relying on the process which adopts novel approaches and involves the concept of ADMET (i.e., absorption, distribution, metabolism, excretion, and toxicity) in the early stages of drug discovery along with the interaction profiles of herb-herb and herb-synthetic. In the present review, we will address the noteworthy opportunities and issues related to phyto-drug improvement in various developing and developed nations such as Europe, U.S. and India, its commercialization with regulatory guidelines, and recommended potential methods to bring them up into the mainstream of modern medical practices and healthcare.

10 May 2022 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
NPNabanita Panja
Nabanita Panja
SMSumana Maji
Sumana Maji
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
KAKazi Asraf Ali
Kazi Asraf Ali
CHChowdhury Mobaswar Hossain
Chowdhury Mobaswar Hossain

29 September 2023 in Bioprinting
Verified
Journal Article
Closed access
KAKazi Asraf Ali
Kazi Asraf Ali
SCSabyasachi Choudhuri
Sabyasachi Choudhuri
SMSk Mohin
Sk Mohin
SGSusmita Goswami
Susmita Goswami

5 August 2025 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
ABAmlan Bishal
Amlan Bishal
PPPriyadarshini Paul
Priyadarshini Paul
SBSayan Bera
Sayan Bera
DPDipsikha Patra
Dipsikha Patra
BBBratati Bandyopadhyay
Bratati Bandyopadhyay
KAKazi Asraf Ali
Kazi Asraf Ali